Literature DB >> 2324270

Use of Haemophilus test medium for broth microdilution antimicrobial susceptibility testing of Streptococcus pneumoniae.

J H Jorgensen1, L A Maher, A W Howell.   

Abstract

A recently described medium (Haemophilus test medium [HTM]) for antimicrobial susceptibility testing of Haemophilus influenzae was evaluated in this study for broth microdilution testing of Streptococcus pneumoniae. A total of 137 clinical isolates was tested against 11 antimicrobial agents, using Mueller-Hinton broth supplemented with 3% lysed horse blood in parallel with HTM. Inocula of 5 X 10(5) CFU/ml and incubation for 20 to 24 h were used with both media. All isolates of S. pneumoniae produced acceptable growth in both media, and MICs determined in HTM agreed closely with those determined in lysed horse blood. Drugs which provided a MIC within 1 log2 concentration difference in both media included penicillin (100%), ampicillin (98.0%), amoxicillin-clavulanate (100%), ampicillin-sulbactam (100%), cephalexin (98.9%), cefaclor (96.8%), cefuroxime (99.0%), chloramphenicol (96.2%), tetracycline (96.2%), and erythromycin (100%). HTM MICs with trimethoprim-sulfamethoxazole were 1 to 2 log2 concentration increments higher in 92.0% of isolates than MICs determined in lysed horse blood. Based on the results of this study, HTM appears to represent a promising alternative medium for broth microdilution susceptibility testing of S. pneumoniae.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2324270      PMCID: PMC269637          DOI: 10.1128/jcm.28.3.430-434.1990

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  Emergence of multiply resistant pneumococci.

Authors:  M R Jacobs; H J Koornhof; R M Robins-Browne; C M Stevenson; Z A Vermaak; I Freiman; G B Miller; M A Witcomb; M Isaäcson; J I Ward; R Austrian
Journal:  N Engl J Med       Date:  1978-10-05       Impact factor: 91.245

2.  Variation in penicillin-binding protein patterns of penicillin-resistant clinical isolates of pneumococci.

Authors:  Z Markiewicz; A Tomasz
Journal:  J Clin Microbiol       Date:  1989-03       Impact factor: 5.948

3.  Chloramphenicol resistance in Streptococcus pneumoniae: enzymatic acetylation and possible plasmid linkage.

Authors:  A Dang-Van; G Tiraby; J F Acar; W V Shaw; D H Bouanchaud
Journal:  Antimicrob Agents Chemother       Date:  1978-04       Impact factor: 5.191

4.  Quantitative antimicrobial susceptibility test for Streptococcus pneumoniae using inoculum supplemented with whole defibrinated sheep blood.

Authors:  R F D'Amato; J M Swenson; G A McKinley; L Hochstein; A A Wallman; D J Cleri; A J Mastellone; L Fredericks; L Gonzalez; D H Pincus
Journal:  J Clin Microbiol       Date:  1987-09       Impact factor: 5.948

5.  False susceptible penicillin G MICs for Streptococcus pneumoniae with a commercial microdilution system.

Authors:  C J Shanholtzer; L R Peterson
Journal:  Am J Clin Pathol       Date:  1986-05       Impact factor: 2.493

6.  Antimicrobial susceptibility testing of pneumococci: determination of Kirby-Bauer breakpoints for penicillin G, erythromycin, clindamycin, tetracycline, chloramphenicol, and rifampin.

Authors:  M R Jacobs; Y Mithal; R M Robins-Browne; M N Gaspar; H J Koornhof
Journal:  Antimicrob Agents Chemother       Date:  1979-08       Impact factor: 5.191

7.  Relatively penicillin-resistant pneumococcal infections in pediatric patients.

Authors:  M A Jackson; S Shelton; J D Nelson; G H McCracken
Journal:  Pediatr Infect Dis       Date:  1984 Mar-Apr

8.  Special topics in antimicrobial susceptibility testing: test accuracy against methicillin-resistant Staphylococcus aureus, pneumococci, and the sensitivity of beta-lactamase methods.

Authors:  R N Jones; D C Edson
Journal:  Am J Clin Pathol       Date:  1983-10       Impact factor: 2.493

9.  Chloramphenicol and penicillin resistance in pneumococci isolated from blood and cerebrospinal fluid: a prevalence study in metropolitan Denver.

Authors:  G R Istre; J T Humphreys; K D Albrecht; C Thornsberry; J M Swenson; R S Hopkins
Journal:  J Clin Microbiol       Date:  1983-03       Impact factor: 5.948

10.  Improved medium for antimicrobial susceptibility testing of Haemophilus influenzae.

Authors:  J H Jorgensen; J S Redding; L A Maher; A W Howell
Journal:  J Clin Microbiol       Date:  1987-11       Impact factor: 5.948

View more
  14 in total

1.  Multicenter evaluation of the use of Haemophilus test medium for broth microdilution antimicrobial susceptibility testing of Streptococcus pneumoniae and development of quality control limits.

Authors:  J H Jorgensen; G V Doern; M J Ferraro; C C Knapp; J M Swenson; J A Washington
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

2.  Haemophilus test medium versus Mueller-Hinton broth with lysed horse blood for antimicrobial susceptibility testing of four bacterial species.

Authors:  A L Barry; M A Pfaller; P C Fuchs
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-07       Impact factor: 3.267

3.  Development of interpretive criteria and quality control limits for broth microdilution and disk diffusion antimicrobial susceptibility testing of Streptococcus pneumoniae.

Authors:  J H Jorgensen; J M Swenson; F C Tenover; M J Ferraro; J A Hindler; P R Murray
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948

4.  Comparison of antimicrobial susceptibility methods for detection of penicillin-resistant Streptococcus pneumoniae.

Authors:  D L Kiska; A Kerr; M C Jones; N N Chazotte; B Eskridge; S Miller; M Jordan; C Sheaffer; P H Gilligan
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

5.  Antimicrobial activity of the new carbapenem biapenem compared to imipenem, meropenem and other broad-spectrum beta-lactam drugs.

Authors:  H S Sader; R N Jones
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-05       Impact factor: 3.267

6.  In vitro evaluation of E-4695, a new fluoro-naphthyridine.

Authors:  R N Jones
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-02       Impact factor: 3.267

7.  In vitro activity of OPC-17116 compared to other broad-spectrum fluoroquinolones.

Authors:  H S Sader; M E Erwin; R N Jones
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-04       Impact factor: 3.267

8.  Antibacterial activity of the investigational oral and parenteral cephalosporin BK-218.

Authors:  D M Johnson; R N Jones
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-02       Impact factor: 3.267

9.  In vitro activity of E-4868, a new trifluoroquinolone, compared to six similar compounds.

Authors:  M S Barrett; R N Jones; M E Erwin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-02       Impact factor: 3.267

10.  In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. Medical Centers in 1992 and 1993.

Authors:  A L Barry; M A Pfaller; P C Fuchs; R R Packer
Journal:  Antimicrob Agents Chemother       Date:  1994-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.